British Columbia Investment Management Corp Amgen Inc Transaction History

British Columbia Investment Management Corp

$16.2 Billion
Q2 2024

A detailed history of British Columbia Investment Management Corp transactions in Amgen Inc stock. As of the latest transaction made, British Columbia Investment Management Corp holds 102,649 shares of AMGN stock, worth $32.4 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

102,649

Previous 64,112 60.11%

Holding current value

$32.4 Million

Previous $18.2 Million 75.95%

% of portfolio

0.2%

Previous 0.13%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $10.1 Million - $12.3 Million	38,537 Added 60.11%	102,649 $32.1 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $682,123 - $823,408	2,537 Added 4.12%	64,112 $18.2 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $3.32 Million - $3.75 Million	12,988 Added 26.73%	61,575 $17.7 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $69,749 - $86,595	319 Added 0.66%	48,587 $13.1 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $121,276 - $143,407	566 Added 1.19%	48,268 $10.7 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $60,511 - $73,753	268 Added 0.56%	47,702 $11.5 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $1.26 Million - $1.6 Million	-5,503 Reduced 10.4%	47,434 $12.5 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $2.63 Million - $2.97 Million	-11,730 Reduced 18.14%	52,937 $11.9 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $5.17 Million - $5.75 Million	-22,392 Reduced 25.72%	64,667 $15.7 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $2.8 Million - $3.1 Million	-12,773 Reduced 12.79%	87,059 $21.1 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $1.28 Million - $1.46 Million	-6,417 Reduced 6.04%	99,832 $22.5 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $124,814 - $146,235	-588 Reduced 0.55%	106,249 $22.6 Million
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $2.61 Million - $2.9 Million	11,189 Added 11.7%	106,837 $26 Million
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $760,707 - $886,480	-3,428 Reduced 3.46%	95,648 $23.8 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $650,221 - $774,298	-3,005 Reduced 2.94%	99,076 $22.8 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $1.76 Million - $1.95 Million	7,491 Added 7.92%	102,081 $25.9 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $5.84 Million - $7.17 Million	29,536 Added 45.4%	94,590 $22.3 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $13.9 Million - $18.5 Million	-76,459 Reduced 54.03%	65,054 $13.2 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $3.02 Million - $3.89 Million	-15,981 Reduced 10.15%	141,513 $34.1 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $7.26 Million - $8.7 Million	-41,713 Reduced 20.94%	157,494 $30.5 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $187,370 - $219,640	1,124 Added 0.57%	199,207 $36.7 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $9.89 Million - $11.1 Million	-54,680 Reduced 21.63%	198,083 $37.6 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $2.43 Million - $2.84 Million	13,614 Added 5.69%	252,763 $49.2 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $16.6 Million - $18.7 Million	-89,537 Reduced 27.24%	239,149 $49.6 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $19.4 Million - $21.8 Million	-116,664 Reduced 26.2%	328,686 $60.7 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $10.1 Million - $11.8 Million	-59,583 Reduced 11.8%	445,350 $75.9 Million
Q4 2017 Feb 20, 2018	BUY	$168.79 - $188.59 $4.26 Million - $4.76 Million	25,237 Added 5.26%	504,933 $87.8 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $80.2 Million - $91.6 Million	479,696	479,696 $89.4 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Amgen Inc Transaction History